An international group of researchers has assembled the most complete genome sequence of commercial sugarcane. They mapped 373,869 genes or 99.1% of the total genome.
By Luisa Massarani
Brazil is the second country, after Indonesia, to approve the commercial cultivation of GM sugarcane. The approval was announced by the Brazilian National Biosafety Technical Commission (CTNBio) on June 8.
Sugarcane borer is one of the main pests of the sugarcane fields of South-Central Brazil, causing losses of approximately US$1.5 billion per year.
“Breeding programmes could not produce plants resistant to this pest, and the existing chemical controls are both not effective and severely damaging to the environment,” says Adriana Hemerly, a professor at the Federal University of Rio de Janeiro, in an interview with SciDev.Net.
“Studies conducted outside Brazil prove that protein from genetically modified organisms harms non-target insects, soil fauna and microorganisms.”
“Therefore, the [GM variety] is a biotechnological tool that helps solve a problem that other technologies could not, and its commercial application will certainly have a positive impact on the productivity of sugarcane in the country.”
Jesus Aparecido Ferro, a member of CTNBio and professor at the Paulista Júlio de Mesquita Filho State University, believes the move followed a thorough debate that began in December 2015 — that was when the Canavieira Technology Center (Sugarcane Research Center) asked for approval to commercially cultivate the GM sugarcane variety.
“The data does not provide evidence that the cane variety has a potential to harm the environment or human or animal health,” Ferro told SciDev.Net.
To develop the variety, scientists inserted the gene for a toxin [Cry] from the bacterium Bacillus thuringiensis (Bt) into the sugarcane genome, so it could produce its own insecticide against some insects’ larvae.
This is a technology that “has been in use for 20 years and is very safe”, says Aníbal Eugênio Vercesi, another member of the CTNBio, and a professor at the State University of Campinas.
But Valério De Patta Pillar, also a member of the CTNBio and a professor at the Federal University of Rio Grande do Sul, points to deficiencies in environmental risk assessment studies for the GM variety — and the absence of assessments of how consuming it might affect humans and animals.
According to Pillar, there is a lack of data about the frequency with which it breeds with wild varieties. Data is also missing on issues such as the techniques used to create the GM variety and the effects of its widespread use.
Rogério Magalhães, an environmental analyst at Brazil’s Ministry of the Environment, also expressed concern about the approval of the commercial transgenic cane.
“I understand that studies related to the impacts that genetically modified sugarcane might have on Brazilian biodiversity were not done by the company that owns the technology,” said Magalhães in an interview with SciDev.Net. This is very important because Brazil’s climate, species, and soils differ from locations where studies might have taken place, he explained.
Among the risks that Magalhães identified is contamination of the GM variety’s wild relatives. “The wild relative, when contaminated with transgenic sugarcane, will have a competitive advantage over other uncontaminated individuals, as it will exhibit resistance to insect-plague that others will not have,” he explained.
Another risk that Magalhães warns about is damage to biodiversity. “Studies conducted outside Brazil prove that Cry protein from genetically modified organisms harms non-target insects, soil fauna and microorganisms.”
Magalhães added that some pests have already developed resistance to the Bt Cry protein, prompting farmers to apply agrochemicals that are harmful to the environment and human health.